This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of allergy to analgesic agent
Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
232 |
4. Check minimum number of eventsNone |
232 |
5. Include endpointsNone |
232 |
6. Filter based on genotype QC (FinnGen only) |
221 |
Control definitions (FinnGen only)
- Control exclude
- CD2_BENIGN_FEMALE_GEN_OTH
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ASAINTOL
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z88
Similar endpoints
↥List of similar endpoints to
Personal history of allergy to analgesic agent
based on the number of shared cases.
Similar with more cases:
- Personal history of allergy to drugs, medicaments and biological substances
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 221 | 145 | 76 |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | 0.03 |
| Median age at first event (years) | 53.18 | 51.96 | 55.50 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 232
- Matched controls
- 2320
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
+∞
307.7
232
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
221.2
296.1
147
18
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
116.5
244.9
132
26
J33.8
ICD-10 Finland
Other polyp of sinus
129.8
229.9
120
19
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
51.7
201.1
137
63
J45.1
ICD-10 Finland
Nonallergic asthma
37.8
174.8
134
81
UDH02
NOMESCO Finland
Rhinopharyngoscopy
33.1
161.9
130
86
J32.4
ICD-10 Finland
Chronic pansinusitis
420.4
152.4
138
8
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
46.4
145.6
93
33
R03DC03
ATC
montelukast; oral
26.3
143.8
172
228
J45.0
ICD-10 Finland
Predominantly allergic asthma
24.9
142.0
137
127
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
26.4
140.7
177
252
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
20.3
116.8
115
107
TDM10
NOMESCO Finland
Puncture of maxillary antrum
25.6
114.3
92
58
J45.9
ICD-10 Finland
Asthma, unspecified
16.4
107.4
152
241
XQ800
NOMESCO Finland
Prick test
19.2
106.6
104
94
DHB20
NOMESCO Finland
Polypectomy of internal nose
281.8
102.7
98
6
R01AD05
ATC
budesonide; nasal
18.9
100.8
97
85
R03BB04
ATC
tiotropium bromide; inhalant
18.9
97.2
92
78
C01CA24
ATC
epinephrine; parenteral
17.5
96.9
98
93
R01AD08
ATC
fluticasone; nasal
19.8
92.0
196
501
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
58.7
81.9
47
10
ZXA10
NOMESCO Finland
Bilateral
10.3
71.3
119
216
J45
ICD-10 Finland
Asthma
12.2
70.3
88
111
H02AB07
ATC
prednisone; oral
10.6
67.8
99
152
H02AB04
ATC
methylprednisolone; systemic
9.8
64.6
103
175
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
10.7
62.7
86
121
R03AK06
ATC
salmeterol and fluticasone; inhalant
9.3
61.3
101
177
H02AB06
ATC
prednisolone; systemic
14.9
61.2
203
743
R03BA02
ATC
budesonide; inhalant
8.6
61.1
121
260
R03AK08
ATC
formoterol and beclometasone; inhalant
15.4
58.8
57
48
DPA30
NOMESCO Finland
Sphenotomy
89.2
55.3
60
9
R03DA04
ATC
theophylline; systemic, rectal
19.5
50.8
42
26
J33.9
ICD-10 Finland
Nasal polyp, unspecified
133.3
50.2
52
5
M01AE01
ATC
ibuprofen; systemic, rectal
0.2
46.2
115
2012
R03AK07
ATC
formoterol and budesonide; inhalant
6.4
44.7
121
337
R03AC02
ATC
salbutamol; inhalant
14.7
42.2
214
1038
R03BA05
ATC
fluticasone; inhalant
6.1
41.2
108
289
D11AH05
ATC
dupilumab; topical
233.1
39.1
39
*
ZXD10
NOMESCO Finland
Scheduled procedure
5.6
36.8
150
573
395
Kela drug reimbursment
Dupilumab
211.9
35.8
36
*
R03AC12
ATC
salmeterol; inhalant
12.4
35.8
38
36
R03AC13
ATC
formoterol; inhalant
9.8
34.6
44
54
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
11.8
34.5
38
38
ZXE00
NOMESCO Finland
One hour or less
5.4
34.5
155
631
R01AD58
ATC
fluticasone, combinations; nasal
5.1
34.4
126
436
J33
ICD-10 Finland
Nasal polyp
132.1
32.6
34
*
DHB50
NOMESCO Finland
Turbinoplasty
13.1
32.5
33
29
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
14.2
32.1
31
25
Z2221
NOMESCO Finland
Medical doctor
4.7
30.5
124
456
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
8.8
30.3
42
57
ZXE10
NOMESCO Finland
More than one and less than three hours
4.7
30.1
137
547
ZXC95
NOMESCO Finland
Use of surgical navigator
51.2
29.6
35
8
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.4
28.6
37
46
R06AE09
ATC
levocetirizine; oral
5.0
28.2
81
225
WX002
NOMESCO Finland
Sedation and analgesia
4.9
27.7
80
223
R01AD12
ATC
fluticasone furoate; nasal
4.4
27.2
139
593
R01AD09
ATC
mometasone; nasal
5.0
27.2
175
883
R06AX27
ATC
desloratadine; oral
4.3
27.1
129
523
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
8.9
26.7
36
47
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
26.5
105
372
R06AE07
ATC
cetirizine; oral
4.6
26.4
163
791
J46
ICD-10 Finland
Status asthmaticus
26.3
26.2
36
16
R03BA01
ATC
beclometasone; inhalant
5.0
25.7
70
185
R01AD01
ATC
beclometasone; nasal
4.7
25.5
78
226
R96
ICPC
Asthma
6.0
24.0
48
96
R03AC03
ATC
terbutaline; inhalant
4.7
23.8
69
191
WX402
NOMESCO Finland
General anaesthesia
4.3
23.8
85
276
ZXD20
NOMESCO Finland
Day surgery
4.8
23.1
64
170
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
4.7
22.9
67
186
R03BA08
ATC
ciclesonide; inhalant
5.5
22.6
51
114
J01AA02
ATC
doxycycline; systemic
9.2
21.8
217
1416
T78.4
ICD-10 Finland
Allergy, unspecified
7.5
21.5
33
50
4222
FHL
Endonasal etmoidectomy
63.4
20.3
23
*
Z51.6
ICD-10 Finland
Desensitization to allergens
25.3
18.2
25
11
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
5.3
18.1
41
91
J01.0
ICD-10 Finland
Acute maxillary sinusitis
3.4
18.1
103
444
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
18.0
126
614
Z3231
NOMESCO Finland
Registered nurse
3.4
17.8
99
420
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
46.0
17.6
21
5
R06AX13
ATC
loratadine; oral
3.7
17.6
73
257
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.3
17.3
24
32
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.4
17.0
26
39
DHA10
NOMESCO Finland
Biopsy of cavity of nose
32.8
16.4
21
7
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
32.8
16.4
21
7
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
26.8
16.3
22
9
R06AX26
ATC
fexofenadine; oral
4.9
16.0
39
92
R03AK11
ATC
formoterol and fluticasone; inhalant
13.7
15.8
27
22
J01FA09
ATC
clarithromycin; systemic
3.1
15.5
111
536
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
48.6
15.3
18
*
J01FA06
ATC
roxithromycin; oral
3.0
15.0
122
630
D72.1
ICD-10 Finland
Eosinophilia
60.8
15.0
17
*
J45.8
ICD-10 Finland
Mixed asthma
12.1
15.0
27
25
XG474
NOMESCO Finland
Exhalation nntrogen oxide
6.9
14.9
24
38
J31.0
ICD-10 Finland
Chronic rhinitis
4.4
14.8
41
107
J32.8
ICD-10 Finland
Other chronic sinusitis
85.7
14.8
16
*
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
38.8
14.7
18
5
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.1
14.3
164
1012
J01MA14
ATC
moxifloxacin; systemic
4.5
14.3
38
96
R06AX22
ATC
ebastine; oral
3.2
13.7
69
270
R03DX09
ATC
mepolizumab; parenteral
+∞
13.7
13
*
Z01.7
ICD-10 Finland
Laboratory examination
3.3
13.1
59
215
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.9
13.1
31
71
R01BA52
ATC
pseudoephedrine, combinations; oral
2.8
13.0
97
470
ZX112
NOMESCO Finland
Subcutaneous
12.7
12.6
22
19
N02AX02
ATC
tramadol; systemic, rectal
2.7
12.2
120
665
J01FA10
ATC
azithromycin; systemic
2.9
11.6
171
1145
J33.1
ICD-10 Finland
Polypoid sinus degeneration
+∞
11.6
11
*
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
13.7
11.4
19
15
J30.3
ICD-10 Finland
Other allergic rhinitis
5.7
11.3
22
42
XQ820
NOMESCO Finland
Exposure to medicinal substance
45.6
11.0
13
*
L50.9
ICD-10 Finland
Urticaria, unspecified
5.0
10.7
24
52
R02
ICPC
Shortness of breath/dyspnoea
3.5
10.7
42
139
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
10.5
129
777
J01DA06
ATC
[U] cefuroxime
3.1
10.4
52
200
R4110
NOMESCO Finland
Physiotherapy
2.6
10.3
82
403
J02AC02
ATC
itraconazole; systemic
2.8
10.0
59
248
4224
FHL
Endonasal anthrostomy
17.7
10.0
15
9
J01DC02
ATC
cefuroxime; systemic
4.5
9.9
25
60
H65.3
ICD-10 Finland
Chronic mucoid otitis media
8.4
9.9
21
27
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
9.8
128
784
R03DC01
ATC
zafirlukast; oral
12.1
9.7
17
15
S01GX01
ATC
cromoglicic acid; ophthalmic
2.6
9.7
70
326
DJD20
NOMESCO Finland
Plastic repair of septum of nose
5.2
9.5
20
41
3028
Kela drug reimbursment
Mepolizumab
104.1
9.5
10
*
R01AD11
ATC
triamcinolone; nasal
3.6
9.5
34
106
T88.6
ICD-10 Finland
Anaphylactic shock due to adverse effect of correct drug or medicament properly administered
+∞
9.4
9
*
R03DX10
ATC
benralizumab; systemic
+∞
9.4
9
*
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
9.3
58
250
J34.2
ICD-10 Finland
Deviated nasal septum
4.2
9.2
26
68
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.2
9.2
41
147
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.5
9.1
19
24
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
25.2
9.0
12
5
H66.9
ICD-10 Finland
Otitis media, unspecified
3.6
8.8
31
95
Z3226
NOMESCO Finland
Physiotherapist
2.7
8.8
57
250
A07AA02
ATC
nystatin; oral
4.9
8.8
20
44
297, ,
Kela drug reimbursment
+∞
8.4
8
*
3027
Kela drug reimbursment
Benralizumab
+∞
8.4
8
*
251, ,
Kela drug reimbursment
+∞
8.4
8
*
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
18.0
8.2
12
7
4239
FHL
Other measure in this category
34.7
8.1
10
*
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
34.7
8.1
10
*
A02BC05
ATC
esomeprazole; systemic
2.2
8.1
104
620
Z01.8
ICD-10 Finland
Other specified special examinations
2.5
8.0
64
310
UDM02
NOMESCO Finland
Sinoscopy
8.2
8.0
17
22
R01BA01
ATC
phenylpropanolamine; oral
4.3
8.0
21
52
UDC00
NOMESCO Finland
Ear microscopy
3.8
7.9
25
71
J01CA04
ATC
amoxicillin; systemic
3.4
7.7
210
1706
J01DB01
ATC
cefalexin; oral
3.3
7.7
208
1681
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
10.6
7.6
14
14
R06.0
ICD-10 Finland
Dyspnoea
2.4
7.6
67
339
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.8
7.5
41
164
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
82.6
7.5
8
*
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
7.7
7.3
16
22
J01FA15
ATC
telithromycin; oral
3.0
7.3
35
130
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.2
7.1
18
31
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.9
7.0
15
20
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
9.8
6.9
13
14
DPA20
NOMESCO Finland
Trephine of frontal sinus
41.3
6.8
8
*
J01.1
ICD-10 Finland
Acute frontal sinusitis
7.2
6.6
15
22
DFF00
NOMESCO Finland
Pure tone audiometry
3.1
6.6
28
97
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
2.1
6.6
147
1055
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.8
6.5
20
56
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
6.5
96
593
49300
ICD-8 Finland
Asthma, bronchiale
8.5
6.4
13
16
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
7.4
6.3
14
20
R03BB01
ATC
ipratropium bromide; inhalant
6.6
6.3
15
24
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
+∞
6.3
6
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.3
6.2
53
263
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.7
6.2
20
58
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
2.1
6.1
80
470
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.2
6.1
25
85
J30.0
ICD-10 Finland
Vasomotor rhinitis
7.6
6.0
13
18
ZXA05
NOMESCO Finland
Left side
2.2
6.0
57
295
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
73
38
27.57
97.81
1.5
1.1
1.83
5.94
u/ml
1.17
67
21
76
44
25.20
97.28
1.5
1.2
0.45
3.26
u/ml
1.31
69
29
70
35
28.21
95.23
1.5
1.1
0.72
0.93
u/ml
0.14
64
16
207
934
12.29
45.24
5.8
5.6
54.40
57.00
%
2.86
202
882
208
944
12.63
45.17
6.0
5.9
28.12
29.05
%
0.76
203
893
213
1133
11.74
34.76
6.8
9.3
4.08
4.00
e9/l
0.24
179
994
41
13
37.94
32.58
1.3
1.1
1.07
0.09
u/ml
—
26
8
20
35
6.16
11.21
2.4
5.5
58.70
58.34
%
0.04
20
35
20
35
6.16
11.21
2.4
4.6
4.64
4.77
e9/l
0.06
20
35
81
468
2.12
6.53
2.9
2.6
0.13
0.34
e6/l
0.99
51
349
12
14
8.97
6.13
5.0
2.7
—
—
—
0
0
39
173
2.51
5.79
2.1
2.3
39.55
29.34
u/l
0.32
29
142
8
5
16.49
5.45
1.4
1.0
87.75
91.60
%
—
8
5
80
491
1.96
5.29
1.7
1.6
—
—
—
0
0
68
411
1.93
4.62
1.7
1.6
1.82
0.94
mg/l
0.30
53
312
211
1848
2.57
4.32
11.2
9.8
91.42
89.46
ml/min/173m2
0.90
184
1508
32
149
2.33
4.26
3.8
3.0
—
—
—
0
0
14
37
3.96
3.97
1.4
1.3
—
—
—
0
0
12
28
4.46
3.87
1.4
1.2
—
—
—
0
0
12
28
4.46
3.87
1.4
1.2
—
—
—
0
0
19
72
2.79
3.84
2.4
1.6
—
—
—
0
0
232
2225
+∞
3.77
19.0
16.7
41.80
40.71
%
4.91
232
2127
232
2230
+∞
3.58
19.3
16.8
138.18
137.02
g/l
0.76
232
2204
6
209
0.27
3.57
3.0
4.1
34.83
31.61
%
—
6
141
8
13
6.33
3.53
1.0
2.0
—
—
—
0
0
45
260
1.91
3.43
2.0
2.5
1.20
2.66
e6/l
1.07
15
126
20
83
2.54
3.41
6.1
4.3
25.75
25.13
mmol/l
0.36
20
83
10
23
4.49
3.35
1.1
1.3
—
—
—
0
0
20
85
2.48
3.25
2.1
1.5
—
—
—
0
0
84
594
1.65
3.18
3.0
2.7
—
—
—
0
0
31
161
2.07
3.18
1.4
1.7
—
—
—
0
0
11
30
3.80
3.13
7.9
2.6
5.26
5.17
kpa
0.15
11
30
216
1967
2.42
3.07
13.2
11.0
23.85
20.94
mg/l
0.52
183
1478
15
57
2.74
3.03
1.0
1.2
—
—
—
0
0
15
57
2.74
3.03
1.0
1.2
—
—
—
0
0
46
282
1.79
2.90
2.0
2.3
0.33
0.81
e6/l
1.31
15
147
31
168
1.98
2.84
1.5
1.7
—
—
—
0
0
16
66
2.53
2.77
1.2
1.3
—
—
—
0
0
177
1537
1.64
2.62
4.0
3.5
—
—
—
0
0
16
71
2.35
2.40
1.3
1.7
—
—
—
0
0
18
85
2.21
2.35
1.8
1.5
—
—
—
0
0
10
35
2.94
2.23
1.5
1.1
—
—
—
0
0
65
468
1.54
2.18
1.9
2.4
307.48
5671.04
umol/l
1.70
54
419
9
31
2.98
2.09
1.0
1.2
—
—
—
0
0
43
284
1.63
2.07
2.8
3.4
17.28
251.22
ng/l
1.15
25
191
22
122
1.89
1.92
1.0
1.0
—
—
—
0
0
34
218
1.66
1.84
1.6
2.4
4.19
8.36
umol/l
1.43
27
180
12
53
2.33
1.84
1.5
1.5
—
—
—
0
0
5
12
4.23
1.83
1.0
3.2
222.40
628.50
u/ml
—
5
12
41
278
1.58
1.78
2.6
2.4
2.42
2.43
mmol/l
0.29
34
243
22
126
1.82
1.75
1.4
1.3
17.74
23.66
iu/l
0.56
16
109
37
246
1.60
1.74
1.8
1.8
—
—
—
0
0
164
1454
1.44
1.72
2.4
2.9
30.50
42.71
u/l
5.12
156
1383
200
1845
1.61
1.72
3.3
3.9
5.59
5.78
mmol/l
1.25
183
1723
66
500
1.45
1.70
1.3
1.3
0.72
1.26
u/ml
1.09
13
152
167
1493
1.42
1.61
3.7
4.0
14.14
14.51
pmol/l
1.27
154
1380
65
502
1.41
1.50
1.5
1.7
1.35
1.44
mmol/l
0.41
55
432
111
940
1.35
1.44
3.5
5.8
9.58
10.40
umol/l
0.98
103
893
31
208
1.57
1.42
2.0
1.9
—
—
—
0
0
109
931
1.32
1.30
3.7
4.3
0.00
0.00
estimate
-0.00
22
184
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
16
92
1.79
1.28
1.6
1.5
—
—
—
0
0
92
768
1.33
1.28
2.1
2.3
73.33
74.92
nmol/l
0.22
81
696
84
692
1.34
1.28
2.7
4.4
37.14
36.95
g/l
0.15
75
655
52
397
1.40
1.27
1.8
1.4
—
—
—
0
0
91
760
1.32
1.26
3.5
6.0
1.22
1.22
mmol/l
0.78
73
664
12
212
0.54
1.25
6.3
5.9
—
—
—
0
0
77
628
1.34
1.25
1.8
1.8
93.82
96.00
pmol/l
0.14
38
314
6
25
2.44
1.25
2.3
2.1
—
—
—
0
0
25
165
1.58
1.24
1.5
1.8
—
—
—
0
0
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
5
19
2.67
1.22
1.4
1.2
—
—
—
0
0
5
19
2.67
1.22
1.0
1.2
—
—
—
0
0
0
34
0.00
1.17
0.0
1.0
—
12.50
—
0
6
34
459
0.70
1.14
5.0
3.8
4.67
12.60
mg/mmol
1.54
19
308
108
935
1.29
1.12
2.6
3.1
0.00
0.01
estimate
0.50
23
193
109
945
1.29
1.12
2.6
3.1
0.00
0.02
estimate
0.50
21
177
11
59
1.91
1.09
1.4
1.3
—
—
—
0
0
70
576
1.31
1.06
2.9
3.2
2.34
2.36
mmol/l
0.76
62
516
155
1417
1.28
1.00
5.7
7.2
69.47
74.78
u/l
1.65
147
1321
190
1787
1.35
0.97
4.6
4.7
1.66
1.82
mu/l
1.54
181
1663
7
37
1.92
0.95
1.1
1.1
—
—
—
0
0
16
103
1.59
0.90
1.7
1.5
—
—
—
0
0
10
56
1.82
0.89
1.3
1.8
—
—
—
0
0
5
100
0.49
0.79
1.0
1.4
—
—
—
0
0
18
126
1.46
0.73
1.2
1.3
—
—
—
0
0
204
1961
1.33
0.70
3.7
4.3
2.89
2.88
mmol/l
0.07
190
1847
14
94
1.52
0.68
1.3
1.3
355.16
298.92
miu/ml
—
5
45
102
916
1.20
0.68
3.0
2.8
98.24
88.42
ug/l
0.12
94
857
31
244
1.31
0.65
2.1
3.0
0.83
0.81
mmol/l
0.79
31
232
0
22
0.00
0.59
0.0
3.2
—
66.76
—
0
22
30
240
1.29
0.57
1.8
1.5
1049.33
1212.90
nmol/l
0.35
18
184
5
87
0.57
0.57
1.2
1.6
—
—
—
0
0
6
36
1.68
0.57
1.2
2.5
—
—
—
0
0
12
82
1.49
0.55
1.5
1.4
—
—
—
0
0
6
39
1.55
0.53
1.0
1.1
—
—
—
0
0
31
255
1.25
0.49
3.4
2.6
0.46
0.75
ug/l
2.82
18
148
36
424
0.82
0.47
4.7
4.1
1.48
1.72
ug/l
0.35
31
378
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
5
34
1.48
0.40
2.8
3.2
12.20
17.84
u/ml
—
5
34
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
5
35
1.44
0.39
1.4
1.5
—
—
—
0
0
25
299
0.82
0.38
1.5
1.6
411.53
459.39
pmol/l
0.71
15
266
5
77
0.64
0.36
1.4
1.6
—
—
—
0
0
192
1866
1.17
0.35
2.9
3.6
1.18
1.30
mmol/l
1.52
177
1754
40
353
1.16
0.33
1.4
1.3
11.19
29.62
iu/ml
—
10
123
14
110
1.29
0.32
1.4
1.4
—
—
—
0
0
85
907
0.90
0.29
2.0
2.3
—
—
—
0
0
8
62
1.30
0.28
1.3
1.1
—
—
—
0
0
45
495
0.89
0.26
3.2
3.3
0.00
0.01
estimate
0.50
23
183
12
149
0.79
0.26
2.3
2.1
79.83
73.21
ml/min/173m2
—
6
67
198
1941
1.14
0.24
3.3
4.0
4.87
4.79
mmol/l
0.69
185
1842
197
1932
1.13
0.23
3.3
3.9
1.56
1.47
mmol/l
2.09
183
1824
0
11
0.00
0.21
0.0
8.6
—
34.00
—
0
5
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.9
—
16.11
—
0
12
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
124.64
—
0
13
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1.17
—
0
7
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
6
50
1.21
0.20
4.2
3.5
10.83
217.14
u/ml
—
6
42
18
204
0.87
0.17
2.7
5.2
1.12
1.01
mmol/l
1.23
18
188
7
87
0.80
0.15
1.1
1.9
—
—
—
0
0
42
398
1.07
0.11
2.0
2.1
—
—
—
0
0
101
1033
0.96
0.08
3.5
3.8
6.17
6.50
mmol/l
1.13
95
947
72
699
1.04
0.08
11.5
9.3
1.05
1.15
inr
1.04
28
217
6
75
0.79
0.07
1.5
2.4
0.92
1.41
%
—
6
75
76
741
1.04
0.07
2.6
3.0
—
—
—
0
0
19
177
1.08
0.07
1.6
1.5
—
—
—
0
0
63
616
1.03
0.04
2.6
3.0
15.21
40.73
ng/l
1.88
28
355
34
352
0.96
0.04
1.3
1.3
5.11
7.89
u/ml
0.31
15
148
57
559
1.03
0.03
1.9
2.4
50.43
55.55
u/l
1.50
49
522
37
360
1.03
0.03
2.0
2.0
—
—
—
0
0
32
328
0.97
0.02
3.9
3.9
18.75
20.97
%
—
8
135
16
153
1.05
0.01
4.8
6.6
1.60
1.25
mmol/l
0.16
11
122
25
257
0.97
0.01
1.6
1.6
—
—
—
0
0
43
436
0.98
0.00
1.7
2.0
—
—
—
0
0
37
374
0.99
0.00
1.9
2.7
382.85
715.98
ng/l
1.42
30
302
173
1726
1.01
0.00
4.1
4.7
37.76
38.65
mmol/mol
0.65
162
1632
18
175
1.03
0.00
4.0
5.3
105.56
103.92
mmol/l
0.75
18
175
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
1928.33
—
0
9
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
53
0.94
-0.00
1.2
1.6
—
0.01
—
0
7
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
6
66
0.91
-0.00
1.3
2.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.6
—
57.30
—
0
5
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
2.3
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_ALLERGY_ANALGESIC_AGENT – Personal history of allergy to analgesic agent
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).